Loading clinical trials...
Loading clinical trials...
Improving Colorectal Cancer Screening: Using Narrow Band Imaging for Colonic Sessile Serrated Lesions
Colorectal cancer (CRC) is a leading cause of cancer death and its' incidence is rising in most European countries. Colonoscopy has been shown to reduce CRC incidence, however its effectiveness depends on the sensitivity to detect pre-malignant lesions. Our aim is to evaluate narrow band imaging (NBI) during colonoscopy and serum miRNAs as novel tools for the early detection of colonic sessile serrated lesions (SSL). The investigators will perform a multicenter-randomized-controlled-trial to study the role of NBI in SSL detection.
Age
40 - 80 years
Sex
ALL
Healthy Volunteers
Yes
Hospital Beatriz Ângelo
Loures, Portugal
Centro Hospitalar do Porto
Porto, Portugal
Instituto Português de Oncologia do Porto
Porto, Portugal
Start Date
November 1, 2016
Primary Completion Date
August 1, 2019
Completion Date
August 1, 2019
Last Updated
September 26, 2018
987
ESTIMATED participants
narrow band imaging withdrawal
DEVICE
white light withdrawal
DEVICE
Lead Sponsor
Hospital Beatriz Ângelo
NCT04704661
NCT04674267
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions